Through difference analysis of survival, results indicated the expression of AKR1B1, PLD1, and UGT8 were death risk relative genes, while AGPAT3 was expressed higher in GC patients with better prognosis (Figure 3C). This evidence concerns the gene AKR1B1 and gastric cancer.